JPWO2021055594A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021055594A5 JPWO2021055594A5 JP2022506595A JP2022506595A JPWO2021055594A5 JP WO2021055594 A5 JPWO2021055594 A5 JP WO2021055594A5 JP 2022506595 A JP2022506595 A JP 2022506595A JP 2022506595 A JP2022506595 A JP 2022506595A JP WO2021055594 A5 JPWO2021055594 A5 JP WO2021055594A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- cys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962903441P | 2019-09-20 | 2019-09-20 | |
| US62/903,441 | 2019-09-20 | ||
| US202062990693P | 2020-03-17 | 2020-03-17 | |
| US62/990,693 | 2020-03-17 | ||
| US202063048561P | 2020-07-06 | 2020-07-06 | |
| US63/048,561 | 2020-07-06 | ||
| PCT/US2020/051255 WO2021055594A1 (en) | 2019-09-20 | 2020-09-17 | T-cell modulatory polypeptides and methods of use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022548472A JP2022548472A (ja) | 2022-11-21 |
| JP2022548472A5 JP2022548472A5 (https=) | 2023-09-25 |
| JPWO2021055594A5 true JPWO2021055594A5 (https=) | 2023-09-25 |
| JP7756072B2 JP7756072B2 (ja) | 2025-10-17 |
Family
ID=74884186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506595A Active JP7756072B2 (ja) | 2019-09-20 | 2020-09-17 | Ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220143063A1 (https=) |
| EP (1) | EP4030897A4 (https=) |
| JP (1) | JP7756072B2 (https=) |
| KR (1) | KR20220066075A (https=) |
| CN (1) | CN114423284A (https=) |
| AU (1) | AU2020348373A1 (https=) |
| CA (1) | CA3146591A1 (https=) |
| IL (1) | IL290635A (https=) |
| MX (1) | MX2022003367A (https=) |
| TW (1) | TW202126683A (https=) |
| WO (1) | WO2021055594A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| TWI856047B (zh) * | 2018-12-19 | 2024-09-21 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| US12453774B2 (en) * | 2019-11-07 | 2025-10-28 | Genoimmune Therapeutics Co., Ltd. | Tumor immunotherapy polypeptide and application thereof |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
| US11058751B1 (en) | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
| CN116710115A (zh) | 2020-11-20 | 2023-09-05 | 思维疗法股份有限公司 | 用于优化的肽疫苗的组合物和方法 |
| US12275766B2 (en) * | 2020-12-23 | 2025-04-15 | Janssen Biotech, Inc. | Neoantigen peptide mimics |
| JP2024512470A (ja) * | 2021-03-19 | 2024-03-19 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞調節ポリペプチド及びその使用方法 |
| US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
| CN119095882A (zh) * | 2022-04-07 | 2024-12-06 | Cue生物制药股份有限公司 | 免疫细胞结合多肽 |
| CN115820736B (zh) * | 2022-12-08 | 2024-05-10 | 西南大学 | 家蚕丝胶蛋白Ser4在提高蚕丝性能中的应用及其方法 |
| WO2024264007A2 (en) * | 2023-06-23 | 2024-12-26 | Cue Biopharma, Inc. | T-cell modulatory polypeptides and methods of use thereof |
| WO2024264004A2 (en) * | 2023-06-23 | 2024-12-26 | Cue Biopharma, Inc. | T-cell modulatory polypeptides and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3157552T3 (pl) * | 2014-06-18 | 2020-05-18 | Albert Einstein College Of Medicine | Polipeptydy syntac i ich zastosowania |
| CN115873129A (zh) * | 2015-03-23 | 2023-03-31 | 约翰·霍普金斯大学 | 由体细胞突变基因编码的hla限制性表位 |
| EP3408279A1 (en) * | 2016-01-27 | 2018-12-05 | CSL Behring Lengnau AG | Recombinant igg fc multimers |
| CA3014458A1 (en) * | 2016-03-02 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| AU2017225787B2 (en) * | 2016-03-03 | 2021-09-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CA3019005A1 (en) * | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) * | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) * | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) * | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) * | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| WO2019139896A1 (en) * | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2021230247A1 (ja) * | 2020-05-12 | 2021-11-18 | 大日本住友製薬株式会社 | 癌を処置するための医薬組成物 |
-
2020
- 2020-09-17 WO PCT/US2020/051255 patent/WO2021055594A1/en not_active Ceased
- 2020-09-17 CA CA3146591A patent/CA3146591A1/en active Pending
- 2020-09-17 AU AU2020348373A patent/AU2020348373A1/en not_active Abandoned
- 2020-09-17 EP EP20865317.0A patent/EP4030897A4/en active Pending
- 2020-09-17 KR KR1020227009918A patent/KR20220066075A/ko not_active Withdrawn
- 2020-09-17 MX MX2022003367A patent/MX2022003367A/es unknown
- 2020-09-17 JP JP2022506595A patent/JP7756072B2/ja active Active
- 2020-09-17 CN CN202080065140.0A patent/CN114423284A/zh active Pending
- 2020-09-18 TW TW109132369A patent/TW202126683A/zh unknown
-
2022
- 2022-01-25 US US17/584,133 patent/US20220143063A1/en not_active Abandoned
- 2022-02-15 IL IL290635A patent/IL290635A/en unknown
-
2024
- 2024-10-01 US US18/903,947 patent/US20250120996A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021055594A5 (https=) | ||
| US20230399415A1 (en) | Twin Immune Cell Engager | |
| JP2020514375A5 (https=) | ||
| JP2018525006A5 (https=) | ||
| CA3089333C (en) | Anti-pdl1, il-15 and tgf-beta receptor combination molecules | |
| CN110785435B (zh) | 与il-12和il-18的基于il-15的融合物 | |
| JP6722189B2 (ja) | 単量体Ｆｃドメイン | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| JP2020511949A5 (https=) | ||
| IL277398B1 (en) | Pd-l1 binding affimers, and uses related thereto | |
| JP2017519491A5 (https=) | ||
| CN110914308A (zh) | 改进的双特异性多肽分子 | |
| JP2021500855A5 (https=) | ||
| CA3076099A1 (en) | Linkers for chimeric antigen receptors | |
| US20210269547A1 (en) | Antibody tumor-targeting assembly complexes | |
| JP2019525771A5 (https=) | ||
| JP7749319B2 (ja) | Ｃｔｌａ－４変異型免疫調節タンパク質およびそれらの使用 | |
| RU2018109426A (ru) | Химерные антигенные рецепторы со встроенными контролируемыми функциями | |
| JP7783164B2 (ja) | 改変インターロイキン２受容体ベータアゴニスト | |
| JP2023512452A (ja) | Ｂｃｍａ指向性細胞免疫療法組成物および方法 | |
| JPWO2020243315A5 (https=) | ||
| CN116981470A (zh) | T细胞调节多肽和其使用方法 | |
| JPWO2021239812A5 (https=) | ||
| CA3146903A1 (en) | Modified cytotoxic t cells and methods of use thereof | |
| GB2619410A (en) | Methods and compositions for cellular therapy |